Characterization of monoclonal antibodies to the envelope proteins of an immunodeficiency virus of African green monkeys, SIV agmTYO‐7

1993 ◽  
Vol 22 (4) ◽  
pp. 263-268
Author(s):  
Ahlert Otteken ◽  
Sigrid Nick ◽  
Wolfgang Bergter ◽  
Wolfgang Lüke ◽  
Christiane Stahl‐Hennig ◽  
...  
2004 ◽  
Vol 78 (6) ◽  
pp. 2994-3002 ◽  
Author(s):  
Anne Op De Beeck ◽  
Cécile Voisset ◽  
Birke Bartosch ◽  
Yann Ciczora ◽  
Laurence Cocquerel ◽  
...  

ABSTRACT Hepatitis C virus (HCV) encodes two envelope glycoproteins, E1 and E2, that assemble as a noncovalent heterodimer which is mainly retained in the endoplasmic reticulum. Because assembly into particles and secretion from the cell lead to structural changes in viral envelope proteins, characterization of the proteins associated with the virion is necessary in order to better understand how they mature to be functional in virus entry. There is currently no efficient and reliable cell culture system to amplify HCV, and the envelope glycoproteins associated with the virion have therefore not been characterized yet. Recently, infectious pseudotype particles that are assembled by displaying unmodified HCV envelope glycoproteins on retroviral core particles have been successfully generated. Because HCV pseudotype particles contain fully functional envelope glycoproteins, these envelope proteins, or at least a fraction of them, should be in a mature conformation similar to that on the native HCV particles. In this study, we used conformation-dependent monoclonal antibodies to characterize the envelope glycoproteins associated with HCV pseudotype particles. We showed that the functional unit is a noncovalent E1E2 heterodimer containing complex or hybrid type glycans. We did not observe any evidence of maturation by a cellular endoprotease during the transport of these envelope glycoproteins through the secretory pathway. These envelope glycoproteins were recognized by a panel of conformation-dependent monoclonal antibodies as well as by CD81, a molecule involved in HCV entry. The functional envelope glycoproteins associated with HCV pseudotype particles were also shown to be sensitive to low-pH treatment. Such conformational changes are likely necessary to initiate fusion.


1994 ◽  
Vol 10 (12) ◽  
pp. 1659-1667 ◽  
Author(s):  
FRANÇOIS TRAINCARD ◽  
MARIE-ANNE REY-CUILLÉ ◽  
ISABELLE HUON ◽  
SYLVIE DARTEVELLE ◽  
JEAN-CLAUDE MAZIÉ ◽  
...  

2005 ◽  
Vol 79 (19) ◽  
pp. 12311-12320 ◽  
Author(s):  
Jonathan D. Steckbeck ◽  
Irina Orlov ◽  
Andrew Chow ◽  
Heather Grieser ◽  
Kenneth Miller ◽  
...  

ABSTRACT Increasing evidence suggests that an effective AIDS vaccine will need to elicit both broadly reactive humoral and cellular immune responses. Potent and cross-reactive neutralization of simian immunodeficiency virus (SIV) and human immunodeficiency virus type 1 (HIV-1) by polyclonal and monoclonal antibodies is well documented. However, the mechanisms of antibody-mediated neutralization have not been defined. The current study was designed to determine whether the specificity and quantitative properties of antibody binding to SIV envelope proteins correlate with neutralization. Using a panel of rhesus monoclonal antibodies previously characterized for their ability to bind and neutralize variant SIVs, we compared the kinetic rates and affinity of antibody binding to soluble envelope trimers by using surface plasmon resonance. We identified significant differences in the kinetic rates but not the affinity of monoclonal antibody binding to the neutralization-sensitive SIV/17E-CL and neutralization-resistant SIVmac239 envelope proteins that correlated with the neutralization sensitivities of the corresponding virus strains. These results suggest for the first time that neutralization resistance may be related to quantitative differences in the rates but not the affinity of the antibody-envelope interaction and may provide one mechanism for the inherent resistance of SIVmac239 to neutralization in vitro. Further, we provide evidence that factors in addition to antibody binding, such as epitope specificity, contribute to the mechanisms of neutralization of SIV/17E-CL in vitro. This study will impact the method by which HIV/SIV vaccines are evaluated and will influence the design of candidate AIDS vaccines capable of eliciting effective neutralizing antibody responses.


1991 ◽  
Vol 72 (8) ◽  
pp. 1863-1869 ◽  
Author(s):  
M. Sugiyama ◽  
N. Minamoto ◽  
T. Kinjo ◽  
N. Hirayama ◽  
K. Asano ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document